
The new reality of persistent inflation, supply chain volatility, and rising costs have reshaped procurement strategies across medical group practices and health systems, making strategic purchasing decisions even more crucial. The 2025 Medical Group Purchasing and Supply Chain Report, developed by MGMA in collaboration with MGMA BestPrice, offers a new and timely look at these real-world challenges and the strategies healthcare leaders are using to strengthen their organizations' supply resilience, optimize purchasing, and protect margins.
Drawing on feedback from medical group and health system procurement and operations leaders across a wide range of practice types and ownership structures, this report uncovers critical findings on:
- How inflation and product shortages are driving costs higher at a time of heightened financial strain;
- Where group purchasing organizations (GPOs) like MGMA BestPrice are driving meaningful savings and stability; and
- What strategies — such as inventory optimization and supplier diversification — are proving effective at mitigating future disruptions.
As medical practices work to tighten budgets, the report highlights key opportunities for improving procurement performance, from benchmarking supply costs against industry peers to smarter investments in analytics and technology. Whether you're managing supply challenges today or planning to avoid tomorrow's risks, this report equips you with the intelligence needed to adapt in the face of rapidly evolving challenges.
MGMA members enjoy exclusive access to this free report. Log in or become an MGMA member today to discover how practice leaders and MGMA BestPrice are leading the strategies that can help your organization build a stronger, more resilient supply chain for 2025 and beyond.